New MRI method can identify early signs of Parkinson's

Using quantitative magnetic resonance imaging, researchers were recently able to visualize early structural changes related to Parkinson’s disease

The researchers achieved this by developing an analysis method targeted specifically towards imaging of the striatum—a part of the brain that is known to deteriorate as Parkinson’s progresses.  

“Mapping structural spatial change (i.e., gradients) in the striatum is essential for understanding the function of the basal ganglia in both health and disease,” lead author Professor Aviv Mezer, of the Edmond and Lily Safra Center for Brain Sciences at the Hebrew University of Jerusalem (HU), and colleagues explained. 

The analysis was conducted on 23 young adults aged 23 to 31 and 18 older adults aged 55 to 75. Researchers completed quantitative magnetic resonance imaging (qMRI) of the brain for each participant, followed by a detailed, multi-step cognitive and image analysis (see here). 

The in-depth imaging analysis revealed abnormal gradients of the putamen in individuals with Parkinson’s disease—specifically, the posterior putamen. This could explain the dopaminergic loss and motor dysfunction of patients with the neurological condition, the authors explained. 

“In generalizing our analysis to clinical MRI, we uncovered an in vivo microstructural correlate of PD, which is associated with both dopamine loss and disease-related motor function impairments. We further demonstrated cortico-striatal relations by showing a structural dependency between striatal position and cortical hierarchy.” 

Including both younger and older participants enabled the researchers to compare aging-related microstructural changes of the striatum. In doing so, they found that they connected normal aging to asymmetry increases in anterior and posterior segments of the caudate. In comparison, PD patients displayed alterations of the posterior segments of the putamen. 

The researchers are planning to use their technique to analyze microstructures in other regions of the brain, while also working on developing a qMRI method that can be incorporated into clinical settings, with an anticipated timeline of three to five years. 

The detailed research and techniques discussed in this article can be viewed in full in Science Advances

Related neuroimaging news: 

Experts use MRI to pinpoint link between pediatric TBI and cognitive impairment

Pop-up assessment reduces unnecessary use of head CTs in pediatric trauma settings

'One-stop-shop' CT protocol saves time, reduces radiation needed for acute stroke imaging

We can now diagnose Alzheimer's using only an MRI and an algorithm

New 7T MRI scanners could increase radiologists' role in treating neurological conditions

Hannah murhphy headshot

In addition to her background in journalism, Hannah also has patient-facing experience in clinical settings, having spent more than 12 years working as a registered rad tech. She joined Innovate Healthcare in 2021 and has since put her unique expertise to use in her editorial role with Health Imaging.

Around the web

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.

The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer. 

AI-enabled coronary plaque assessments deliver significant value, according to late-breaking data presented at TCT. These AI platforms have gained considerable momentum in recent months, receiving expanded Medicare coverage in addition to a new Category I CPT code.

Trimed Popup
Trimed Popup